© 2023 Four 20 Pharma
Four 20 Pharma expands product portfolio
New cannabis strain Sour Kush available now.
Paderborn, August 02, 2021 - Four 20 Pharma GmbH, manufacturer, wholesaler and importer of medical cannabis and medical devices, will launch "420 NATURAL 18/1 CA SRK", another cannabis product under its own "420" brand, on the German market from August 2021. The variety represents a first addition to the already existing 420 range of unirradiated, hand-picked buds.
Like Gorilla Glue (GG4), the variety Sour Kush (SRK) is to be classified as an indica-dominant hybrid due to its phenotype characteristics. The supplier has EU GMP certification from a German authority, so compliance with quality standards along the entire production process is also ensured here.
Product quality has top priority
With the "420 NATURAL 18/1 CA SRK", Four 20 Pharma GmbH continues its product line for qualitative, hand-picked, medical cannabis. This new "420" cannabis product is also characterized by the fact that it has not been subjected to any irradiation and still maintains DAB compliance. This means it is 100% natural and has an unaltered terpene profile that would otherwise be affected by irradiation.
Outlook: More cannabis products in the pipeline
In addition to the first product line extension of the "420 series" with the cannabis product " 420 NATURAL 18/1 CA SRK", Four 20 Pharma GmbH is currently already working on the introduction of further cultivars in order to be able to offer a broader product portfolio to patients in the future.
The company aims to meet the different needs of patients in terms of THC and CBD content, terpene profiles and administration and works in cooperation with qualified partners worldwide. Thus, different suppliers and cultivars are regularly tested and analyzed, always with the aim of providing the optimal product range for the market.
The new cannabis products are intended for pharmacies and medical facilities and are available immediately:
Product name: 420 NATURAL 18/1 CA SRK
THC approx. 18 % | CBD < 1 % | Indica dominant hybrid
Order quantity: commercial units of 5 g, 15 g and 100 g
Press contact:
Christopher Thiele
presse@pharma.eu
+49 5251 39032-10
About Four 20 Pharma GmbH
Four 20 Pharma GmbH is GDP and GMP certified as a manufacturer, wholesaler and importer of medical cannabis as well as medical devices. The company, based in Paderborn, Germany, was founded in 2018 and holds a narcotics license according to § 3 BtMG and a medicinal product wholesale license according to § 52a AMG for the whole of Europe. In addition, the medical cannabis specialist holds the necessary import licenses for the importation of medical cannabis into Germany, a manufacturing permit, and the necessary, product-specific permit in accordance with § 7 AMG and § 1 AMRadV for the marketing of medicinal products. Four 20 Pharma GmbH is committed to the Association for Cannabis as Medicine (ACM) as a gold sponsor. The company supports physicians, pharmacies, medical institutions and patients as a reliable partner in the field of medical cannabis. For more information, please visit our website at www.420pharma.de.
